Delivery Order SPE2DB24D3015-SPE2DB25FGBAD
Award Date 9/18/25
Potential Completion Date 9/19/25
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $29,737.84 and an ultimate completion date of September 10, 2025. The contract was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with a ceiling value of $16,626.57. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by April 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $47,776.79 on September 17, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30s under a firm fixed-price contract type. This is a non-set-aside award supporting the Department of Defense Medical Supply Chain, with performance at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is expected to be completed by September 18, 2025. DESCOVY is an antiretroviral medication used...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $8,526.60 to supply DESCOVY 200-25 mg tablets in quantities of 30 units. The contract, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, utilizes firm fixed pricing and is not designated as a set-aside contract. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $24,347.36 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, issued competitively under open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. DESCOVY is an antiretroviral medication...
- The Defense Logistics Agency awarded a delivery order valued at $30,140.34 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV prevention and treatment,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of DESCOVY (200-25mg tablets, 30-count package) valued at $63,967.33. This firm fixed-price delivery order, due for completion by September 23, 2025, represents a competitive award with no set-aside designation. The contract executes against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,303.18 on August 28, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $32,034.58 on May 12, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of May 13, 2025. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a $47,021.50 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of DESCOVY 200-25 mg tablets (30-unit packs). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order...